Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Red sled is closed for repairs
If CaverStem and FemCelz are not good enough for you, don’t forget that StemSpine is waiting on deck. https://www.creativemedicaltechnology.com/stemspine/stemspine-procedure/
We agree again Wolf! May I ask you what will satisfy you revs wise when the Q is out?
Thanks tip.... I just stick to the facts and my DD and try to share.
Thomas Ichim PhD
Dr. Ichim has 20 years experience in the biotechnology industry, having served as the Vice President of Cellular Therapies, Intrexon, Inc. Dr. Ichim is an accomplished inventor and was the President and Chief Scientific Officer at Medistem, Inc., a recently acquired publicly traded company. Dr. Ichim has a PhD in Immunology from University of Sciences Arts and Technology, Olveston Monserrat, a MSc in Microbiology and Immunology from University of Western Ontario, London, Ontario, Canada and a BSc in Biology from the University of Waterloo, Waterloo, Ontario, Canada. Dr. Ichim has written over 100 peer reviewed publications and has founded and operated successful biotech companies in the past.
Amit Patel MS MD
Chief of Cardiac Surgery at the University of Miami Health System. Dr. Patel has an MD from Case Western Reserve University. Dr. Patel is an accomplished inventor and has contributed to the formulation of the Company’s Bionutraceutical® products.
Donald Dickerson MBA
Mr. Dickerson has a Masters of Business Administration, Finance from the University of Southern California. Mr. Dickerson has worked in a number of management and accounting positions and has experience with companies in the technology, manufacturing and health sciences area. Mr. Dickerson’s experience includes leadership positions at BioRasi, Dell, Boeing Capital and Medistem, Inc.
So, these are the folks that some call idiots and accuse of running a scam company. Hmmmm.
I would do your own DD
Timothy Warbington
Mr. Warbington has over 25 years of executive level management and ownership experience. Mr. Warbington has been a lifescience investor for over 12 years. Since 2011 he has been the CEO of Creative Medical Health, Inc. and Creative Medical Technology Holdings, Inc., a public company and since 2012, CEO of iBiologics, a spin off from the University of Utah. In connection with this experience, he has built a network of scientists, physicians and executives to participate as executive officers and directors of CMH.
Nope, the 3 have a vested interest and IMO, won’t touch this below .01.
Who said notes are dead? They are all in the filings.
I don’t think so. The uncontrolled note is dead and gone as of the 14th. The other notes are far more controlled, have safeguards in place and are not due. If they are smart, and not being paid off, even they know to wait until the PPS is far higher. The second sentence I would agree with.
Red sled is dead. Watch
Interesting chart on this tweet regarding the RSI. https://twitter.com/wininlife2/status/1129198796330754048?s=21
Point taken, many are cautious and you can’t blame them. But I am confident that many are watching closely and are starting to see what I see. You are spot on that we will see how it plays out after the Q and the next several weeks. The trading is a small sample for sure, but still telling that the toxic note was killed on May 14 and the others held by the institutional investors are not due and are structured better. We shall see.
I still think that with CELZ being a QB, they pay for that, that they are motivated to get back in good standing. That makes these sub pennies an easy buy IMO.
Very likely. Traders are seeing the toxic note is DOA and that it is clear as can be that the Q will show the highest revs since commercialization of Caverstem. It’s also very clear that CELZ is motivated to get back in good standings on the QB requirements of staying over .01. Buy and hold here is all but a guarantee IMO. Of course some folks will day trade and buy in the 7’s and sell in the 8’s and some folks will claim dilution, but reading the filings investors know better. It’s been normal trading since the toxic note ended.
IMO, anyone doing decent DD can see that the providing doctors are excited by all initial results of Caverstem and have been buying kits and treating patients. The patients are having very good results and that will all be known and published in a few short weeks.
This is happening in the USA and Rome/Europe. The tinder is glowing and the fire will start soon IMO. These sub penny shares will not last much longer. I am adding whenever I can.
Do your DD!
Red sled be dead bro
WRONG on every count. Mark it.
Nope, the trial ended on that day, The review started after that.
You can follow here...... https://clinicaltrials.gov/ct2/show/NCT03699943
Yup, April 4 close of .0102. And yup, after the 90 days to get back in good standing, and fail to do so, you right? It would have to be no longer listed or quoted from the OTCQB. You don’t have to worry about any of that anyway.
I am glad you brought that up. Yessir, that is who CELZ is waiting for, Dr Jacob Rajfer. Now he has some nice credentials doesn’t he. That’s why it worth the wait, a cherry on too with his signature. Patients, you will get to read it soon enough. MontetheLUCKY
Nasdaq.com says April 4, 2019, but you use whatever date is cool. What’s 2 days between friends. And again, from the rules YOU posted a few days ago....
OTC Markets Group Inc. OTCQB Standards (v 3.2 April 16, 2019) Page 11 of 17
Companies are granted a cure period of 90 calendar days for failure to maintain the minimum bid price set forth in Section 2.3(2). In the event that the minimum closing bid price for the Company’s common stock falls below $0.01 per share for 30 consecutive days, a grace period of 90 calendar days to regain compliance shall begin, during which the minimum closing bid price for the Company’s common stock must be $0.01or greater for ten consecutive trading days. In the event that the Company’s closing bid price falls below $0.001 at any time for five consecutive trading days, the Company will be immediately removed from OTCQB.
Bottom line, yes, we will get there. Sooner than later.
Last one was April 4. Which is exactly why this is such a smart time to buy. Revs are increasing with each doctor signed and CELZ is motivated to get back solid over .01. Smart folks are buying
In reference to your last sentence. I think that is exactly what they are doing. Just slower than the market and you and I like. When they have the infrastructure in place, they will be yelling from the rooftops and TV stations!!!
I would agree that things have been glacial, especially for the OTC. And as I have opined, I think one reason was leaving the old centrifugal procedure behind for the new process. But that only explains the last quarter of 2018. I still think, and will always think this way until proven otherwise, that a ton is going on behind the scenes and it is bearing fruit now. Anyway, I think the blunted parts is fair too. What they tell us they tell their competition.
It’s coming PhD. Go watch the doc videos.
Very true, I am aware of that. So, when you watch the videos posted by the treating doctors, you also think they are lying, part of the scam? You don’t think that they truly are hopeful that this “fix” is just what they were looking for. You don’t believe that the success rate has been high? You also think the boxes are empty and no one is buying the kits? Even Antonini is lying that he used 60 of them? You think the company has lied that doctors respond each month to the physician awareness emails and interest is growing, globally?
What is the good news I am being duped into believing? Where is all this bad news that I am ignoring?
The only thing you can complain about is the PPS that has been victim to normal toxic financing and manipulation using it as fuel to the fire. We have talked for months about the notes and the potential dilution and it’s cap, and we have talked for months about when the company flips from having more revenue than expenditures.
IMO we are nearing that point quickly, but many here refuse to admit the company is cash flowing and the worse notes are behind us. The good thing is, the next 3 quarters will bear that out, won’t they?
Exactly, every company does it, especially at start up when there is no other source of money.
The good things here are that the ugly notes are gone, and that was evident yesterday. The current notes are in the hands of the institutional investors and have much better terms and conditions. Some have already be renegotiated in our favor.
And the biggest thing is that CELZ is cash flowing and the need for further notes is unlikely.
Day traders, flippers will take advantage of the late filing if there is a dip and will flip for beer money. Longs will take advantage and load what they can.
The best reason to load today is the same as it was last week. The Q will be the best one CELZ has had, and they are motivated to keep their QB status, so there is little doubt we move back into the pennies. What's even better is that they have many irons in the fire to stoke it!
Wolf - Once again you are ignoring the big elephant in the room. Having a delay from the auditor, especially when a note cleared withing hours of a filing date, is common and you know it. This company is a QB filer that follows all the rules. The idiots you refer to have excellent credentials and many successes in the past. If a late filing equals them being idiots, I cannot help you sir.
The BIG elephant in the room is the fact that CaverStem is an incredible new medical treatments that is starting to get a buzz and will not be held down for long, and you know that too.
We will continue to see many doctors signing up and bringing in revs. No doubt Q1 will be decent with Rome and NM buying scores of empty boxes, being up to five days late does not change that... LOLOL
I bet we see Sanderson up and running in May, OH, TN, TX and maybe more in June.
I also think once they hit their sweet spot with what they think is enough offices opening, the gloves will come off and it will be heavily marketed.
Revs will kick in, advertising and the TV ads kick in and we will see where this company can run too.
Like we have posted before, 20 offices just cranking out one procedure a day, CaverStem or FemCelz, and revs start piling in.
It’s all happening right before our eyes! B&L if you want, but make sure you load.
Exactly. Many companies file late notices. All part of business. It doesn’t change any of the awesome things happening here.
None of those things are debunked. Sheesh.
Second time since 2016. Makes sense with yesterday’s deadline.
Yup. Too many bought in the .006’s and want out at .007.
That all he has to work with. The company is about as solid as they come. Fully reporting, really picking up steam.
Very likely with the note gone. Normal trading and EVERONE knows revs will be up and they need to base over .01. Easy easy buy below .01.
More like this JD.....
OTC Markets Group Inc. OTCQB Standards (v 3.2 April 16, 2019) Page 11 of 17
Companies are granted a cure period of 90 calendar days for failure to maintain the minimum bid price set forth in Section 2.3(2). In the event that the minimum closing bid price for the Company’s common stock falls below $0.01 per share for 30 consecutive days, a grace period of 90 calendar days to regain compliance shall begin, during which the minimum closing bid price for the Company’s common stock must be $0.01or greater for ten consecutive trading days. In the event that the Company’s closing bid price falls below $0.001 at any time for five consecutive trading days, the Company will be immediately removed from OTCQB.
Also, what is your thoughts on StemSpine and AmnioStem. You keep forgetting to offer an opinion. Bigger that CaverStem and FemCelz or not?
We will see plenty here as these doctors keep signing up and bringing in revs. No doubt Q1 will be decent with Rome and NM buying scores of empty boxes LOLOL
I bet we see Sanderson up and running in May, OH, TN, TX and maybe more in June.
I also think once they hit their sweet spot with what they think is enough offices opening, the gloves will come off and it will be heavily marketed.
Revs will kick in, advertising and the TV ads kick in and we will see where this company can run too.
Like we have posted before, 20 offices just cranking out one procedure a day, CaverStem or FemCelz, and revs start piling in.
It’s all happening right before our eyes!
Agreed threeflight. Plus they are in need to keep the QB status, and timing is perfect with the toxic note dead and plenty of news due.
I am seeing a normal trading day....finally, and albeit slim, more buys then sells. Your toxic note is gone and folks are waiting on the revs.